This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Porto-venous Radiomics in Pancreatic Cancer

  • Research type

    Research Study

  • Full title

    Porto-venous Radiomics in Pancreatic Cancer: A multi-centre retrospective cohort study investigating the use of pre-operative CT radiomic features to predict surgical resection margin in pancreatic head malignancy



  • Contact name

    Ricky Bhogal

  • Contact email

  • Sponsor organisation

    The Royal Marsden NHS Foundation trust

  • Identifier

    00, 00

  • Duration of Study in the UK

    1 years, 0 months, 1 days

  • Research summary

    Pancreatic cancers are often inoperable at diagnosis, with only 13-22% of patients being suitable for surgical resection. Surgery is the only curative option, however a majority of those who undergo surgery will suffer from recurrence. This is due to the difficulty in removing the tumour fully, often with microscopic amounts left behind, and the proximity of the pancreas to blood vessels supplying the intestines and liver that cannot be easily removed. An assessment of whether microscopic tumour remains is known as the “resection margin”, and this has been correlated to overall survival after surgery.

    The field of Radiomics, which has emerged over the past 10 years, looks to extract and analyse large amounts of information not usually visible to the human eye from medical images, and is increasingly used in the field of cancer diagnostics. The aim of this study is to employ 3D radiomic analyses to pre-operative Computed Tomography (CT) scan images for cases of pancreatic head cancer that underwent surgical resection, to determine whether this information could be used for modelling to predict operative resection margins and potentially guide additional treatment.

  • REC name

    Yorkshire & The Humber - Leeds West Research Ethics Committee

  • REC reference


  • Date of REC Opinion

    21 Apr 2022

  • REC opinion

    Favourable Opinion